Plasmid condensation induced by cationic compounds: hydrophilic polylysine and amphiphilic cationic lipid

• Autorzy: Chaszczewska-Markowska M , Ugorski M. , Langner M.
• Języki publikacji: EN

Abstrakty

EN

The construction of an efficient carrier for genetic material is a major research objective that needs to be achieved before gene therapy can become a viable pharmacological approach. Artificial aggregates containing nucleic acids are one of the options for the systemic delivery of genetic information. The diversity of functions the aggregate is expected to fulfill necessitates its complex architecture. In order to obtain a complex supramolecular aggregate, formed from elements that are themselves complex molecules, appropriate procedures based on the detailed understanding of processes at the molecular level are required. In this study, we investigated how the various properties of cationic compounds affect nucleic acid condensation. The combination of two condensing agents, differing in their affinity towards water, when mixed with plasmids, resulted in aggregates which are resistant to enzymatic digestion and which form particles with well-defined size distributions. Such uniform and well-defined complexes may subsequently be further modified in order to obtain a fully functional genetic material carrier.

Słowa kluczowe

EN

gene therapy; cationic compound; cationic lipid; polylysine; DNA condensation; plasmid condensation

• Wydawca: -
• Czasopismo: Cellular and Molecular Biology Letters
• Rocznik: 2004
• Tom: 09
• Numer: 1
• Opis fizyczny: p.3-13,fig.,ref.

Twórcy

autor

Chaszczewska-Markowska M

• Polish Academy of Sciences, Weigla 12, 53-114 Wroclaw, Poland

autor

Ugorski M.

autor

Langner M.

Bibliografia

• 1. Bloomfield, V.A. DNA condensation by multivalent cations. Biopoly 44 (1997) 269-282.
• 2. Byk, G., Dubertret, C., Escriou, V., Frederic, M., Jaslin, G., Rangara, R., Pitard, B., Crouzet, J., Wils, P., Schwartz, B. and Scherman, D. Synthesis, activity, and structure-activity relationship studies of novel cationic lipids for DNA transfer. J. Med. Chem. 41 (1998) 224-235.
• 3. Felgner, J.H., Kumar, R., Sridhar, C.N., Wheeler, C.J., Tsai, Y.J., Border, R., Ramsey, P., Martin, M. and Felgner, P.L. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269 (1994) 2550-2561.
• 4. Li, S., Gao, X., Son, K., Sorgi, F., Hofland, H. and Huang, L. DC-chol lipid system in gene transfer. J. Controll Release 39 (1996) 373-381.
• 5. Ren, T. and Liu, D. Synthesis of targetable cationic amphiphiles. Tetrahedron Lett. 40 (1999) 7621-7625.
• 6. Eastman, S.J., Siegel, C., Tousignant, J., Smith, A.E., Cheng, S.H. and Scheule, R.K. Biophysical characterization of cationic lipid: DNA complexes. Biochim. Biophys. Acta 1325 (1997) 41-62.
• 7. Marshall, J., Nietupski, J.B., Lee, E.R., Siegel, C.S., Rafter, P.W., Rudginsky, S.A., Chang, C.D., Eastman, S.J., Harris, D.J., Scheule, R.K. and Cheng, S.H. Cationic lipid structure and formulation considerations for optimal gene transfection of the lung. J. Drug Targeting 7 (2000) 453-469.
• 8. Simberg, D., Danino, D., Talmon, Y., Minsky, A., Ferrari, M.E., Wheeler, C.J. and Barenholz, Y. Phase behavior, DNA ordering, and instability of cationic lipoplexes. J. Biol. Chem. 276 (2001) 47453-47459.
• 9. Langner, M. Effect of liposome molecular composition on its ability to carry drugs. Pol. J. Pharmacol. 52 (2000) 3-14.
• 10. Langner, M. The intracellular fate of non-viral DNA carriers. Cell. Mol. Biol. Lett. 5 (2000) 295-313.
• 11. Palmer, L.R., Chen, T., Lam, A.M.I., Fenske, D.B., Wong, K.F., MacLachlan, I. and Cullis P.R. Transfection properties of stabilized plasmid-lipid particles containing cationic PEG lipids. Biochim. Biophys. Acta 1611 (2003) 204-216.
• 12. Floch, V., Loisel, S., Guenin, E., Herve, A.C., Clement, J.C., Yaouanc, J.J., des-Abbayes, H. and Ferec, C. Cation substitution in cationic phospholipids: a new concept to improve transfection activity and decrease cellular toxicity. J. Med. Chem. 43 (2000) 4617-4628.
• 13. Stuart, D.D. and Allen, T.M. A new liposomal formulation for antisense oligodeoxynucleotides with small size, high incorporation efficiency and good stability. Biochim. Biophys. Acta 1463 (2000) 219-229.
• 14. Tam, P., Monck, M., Lee, D., Ludkovski, O., Leng, E.C., Chow, K., Stark, H., Scherrer, P., Graham, R.W. and Cullis, P.R. Stabilized plasmid-lipid particles for systemic gene therapy. Gene Ther. 7 (2000) 1867-1874.
• 15. Gunning, P., Leavitt, G., Muscat, G., Ng, S.Y. and Kedes L. A human β-actin expression vector system directs high-level accumulation of antisense transcripts. Proc. Natl. Acad. Sci. USA 84 (1987) 4831-4835.
• 16. Sambrook, J., Fritsch, E.F. and Maniatis, T. Molecular cloning, a laboratory manual, second edition, Cold Spring Harbor Laboratory Press, New York, USA, 1989, p. 21.
• 17. Kral, T., Hof, M. and Langner, M. The effect of spermine on plasmid condensation and dye release observed by fluorescence correlation spectroscopy. Biol. Chem. 383 (2002) 331-335.
• 18. Hui, S.W., Langner, M., Zhao, Y.L., Ross, P., Hurley, E. and Chan, K. The role of helper lipids in cationic liposome-mediated gene transfer. Biophys. J. 71 (1996) 590-599.
• 19. Jurkiewicz, P., Okruszek, A., Hof, M. and Langner, M. Associating oligonucleotides with positively charged liposomes. Cell. Mol. Biol. Lett. 8 (2003) 77-84.
• 20. Kreiss, P., Cameron, B., Rangara, R., Mailhe, P., Aguerre-Charriol, O., Airiau, M., Scherman, D., Crouzet, J. and Pitard, B. Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. Nucleic Acids Res. 27 (1999) 3792-3798.
• 21. Pedroso-de-Lima, M.C., Simoes, S., Pires, P., Faneca, H. and Duzgunes, N. Cationic lipid-DNA complexes in gene delivery: From biophysics to biological applications. Adv. Drug Deliv. Rev. 47 (2001) 277-294.